Asynchronous e-learning with technology-enabled and enhanced training for continuing education of nurses: a scoping review.

Publication date: Jul 13, 2023

Asynchronous e-learning has become the mainstream choice since the transformation of learning formats by the coronavirus disease-19 pandemic. This scoping review aimed to examine the technologies used in asynchronous e-learning for the continuing education of clinical nurses and their modes of delivery and effectiveness. This scoping review covered the period between 2011 and 2023. Six databases were searched for relevant studies following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis extension for Scoping Reviews (PRISMA-ScR) protocol. Sixty articles met the inclusion criteria. There was a noticeable trend toward using diverse technology-enabled and enhanced training (TEET) options after 2017. The enabling technological approaches, such as interactive online modules (25 articles) and video modules (25 articles), are described in the articles. The most commonly used enhancing technologies were scenario-based learning (nine articles), resource access (eight articles), computer simulation or virtual reality (three articles), and gamification (three articles). Among the outcomes, knowledge acquisition was the most commonly examined outcome (41 articles). Notably, many interactive TEET modules were used in asynchronous e-learning. There were few studies on gamification, computer simulation or virtual reality, and scenario-based learning (techniques to enhance intrinsic motivation further). However, the adoption of asynchronous e-learning with advanced TEET options is anticipated to increase in the future. Therefore, objective outcome measures are required to determine the effects of such learning methods on knowledge acquisition and behavioral changes.

Open Access PDF

Concepts Keywords
Coronavirus Asynchronous e-learning
Databases Clinical nurses
Education Continuing education


Type Source Name
disease MESH coronavirus disease-19
disease VO effectiveness
disease VO protocol
drug DRUGBANK Methionine
pathway REACTOME Reproduction
disease VO time
drug DRUGBANK Isoxaflutole
drug DRUGBANK Etoperidone
disease VO effective
disease IDO country
drug DRUGBANK Etodolac
drug DRUGBANK (S)-Des-Me-Ampa
disease IDO intervention
disease VO population
drug DRUGBANK Indoleacetic acid
drug DRUGBANK Factor IX Complex (Human)
disease IDO process
drug DRUGBANK Coenzyme M
disease VO Canada
disease MESH pus
disease VO efficient
disease IDO quality
drug DRUGBANK Nonoxynol-9
disease MESH Delirium
disease MESH urinary incontinence
disease MESH sepsis
disease MESH postpartum hemorrhage
drug DRUGBANK Ilex paraguariensis leaf
disease VO frequency
drug DRUGBANK Vancomycin
disease MESH leg ulcer
drug DRUGBANK Bismuth subgallate
drug DRUGBANK Trestolone
disease MESH end of life
disease MESH arthritis
drug DRUGBANK Ambrisentan
disease MESH adverse drug reaction
drug DRUGBANK Gold
disease VO pregnant women
disease MESH dementia

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *